Watchlist Price Alert

IRadimed Corporation (IRMD)

NASDAQ: IRMD · Real-Time Price · USD

52.34

-0.33 (-0.63%)

At close: May 09, 2025, 9:41 AM

-0.63% (1D)

Bid	52.08
Market Cap	665.57M
Revenue (ttm)	75.15M
Net Income (ttm)	19.78M
EPS (ttm)	1.55
PE Ratio (ttm)	33.77
Forward PE	25.42
Analyst	Strong Buy

Ask	54
Volume	829
Avg. Volume (20D)	39,031
Open	52.51
Previous Close	52.67
Day's Range	52.34 - 52.51
52-Week Range	41.60 - 63.29
Beta	0.92

About IRMD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol IRMD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IRMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

IRadimed has released their quartely earnings on May 5, 2025:

Revenue of $19.51M exceeds estimates by $181K, with 10.87% YoY growth.

EPS of 0.42 exceeds estimates by 0.01, with 16.67% YoY growth.

Why Price Moved

2 months ago

-8.38%

Iradimed shares are trading lower. The company rep... Unlock content with Pro Subscription

News

3 days ago · seekingalpha.com

IRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call Transcript

IRADIMED CORPORATION (NASDAQ:IRMD ) Q1 2025 Earnings Conference Call May 5, 2025 9:00 AM ET Company Participants Roger Susi - Founder, President & CEO John Glenn - CFO Conference Call Participants Fra...

3 days ago · zacks.com

IRadimed (IRMD) Lags Q1 Earnings Estimates

IRadimed (IRMD) came out with quarterly earnings of $0.42 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.36 per share a year ago.

1 month ago · seekingalpha.com

IRadimed Corporation: Steady, Low-Risk Grower In The Devices Space

IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, despite recent stock price decline. IRMD's unique MRI-compatible IV infusion pump...

2 months ago · seekingalpha.com

IRADIMED CORPORATION (IRMD) Q4 2024 Earnings Call Transcript

IRADIMED CORPORATION (NASDAQ:IRMD ) Q4 2024 Earnings Conference Call February 13, 2025 11:00 AM ET Company Participants Roger Susi - Founder, President and CEO John Glenn - Chief Financial Officer Con...

2 months ago · zacks.com

IRadimed (IRMD) Lags Q4 Earnings Estimates

IRadimed (IRMD) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.39 per share a year ago.